GlassScriptPhysician profile
Jacqueline Rosenbaum
NPI 1710496757
$1,837.54
in general payments reported to CMS, 2019-2025
21 companies · $688 in 2025
The $688 reported for 2025 was more than what 85% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $190 · 2022: $375 · 2023: $235 · 2024: $348 · 2025: $688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,198 · Education: $73.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,198.49 |
| Education | $73.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $227.04 | 2022-2024 | Wakix |
| Csl Behring | $174.38 | 2022-2025 | Hizentra |
| Regeneron Healthcare Solutions, INC. | $170.35 | 2022-2025 | Dupixent, Libtayo |
| Jazz Pharmaceuticals INC. | $156.19 | 2021-2024 | |
| Incyte Corporation | $145.21 | 2025 | Opzelura |
| Stryker Corporation | $137.35 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $136.61 | 2022-2025 | Cuvitru, Takhzyro |
| Alexion Pharmaceuticals, INC. | $122.88 | 2025 | Koselugo |
| Genzyme Corporation | $88.70 | 2022-2024 | |
| Leo Pharma INC. | $88.54 | 2025 | Adbry, Anzupgo |
| Kaleo, INC. | $66.55 | 2021-2023 | Auvi-Q |
| Abbvie INC. | $60.08 | 2025 | |
| Glaxosmithkline, LLC. | $41.95 | 2024 | Nucala |
| Optinose US, INC. | $41.84 | 2021-2022 | |
| Medtronic, INC. | $40.59 | 2024 | Propel |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $35.57 | 2022-2024 | Airsupra |
| Ucb, INC. | $25.09 | 2025 | Bimzelx |
| Aerin Medical INC. | $21.69 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $20.56 | 2025 | Neffy |
| Grifols USA, LLC | $19.92 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.45 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Rosenbaum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.